Published in J Clin Endocrinol Metab on March 01, 2000
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes (2009) 1.54
Analysis of pathogenesis of juvenile new-onset diabetes. J Diabetes (2011) 1.42
Immunogenetics of type 1 diabetes mellitus. Mol Aspects Med (2015) 0.89
Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses. Math Biosci Eng (2009) 0.82
Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. Pediatr Diabetes (2015) 0.81
Primer: immunity and autoimmunity. Diabetes (2008) 0.80
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression. Diabetes (2016) 0.78
George S. Eisenbarth: insulin and type 1 diabetes. Diabetes Care (2013) 0.76
Latent Autoimmune Diabetes in Adults: Autoimmune Diabetes in Adults with Slowly Progressive β-cell Failure. Diabetes Metab J (2012) 0.75
First test effect in intravenous glucose tolerance testing. Pediatr Diabetes (2013) 0.75
Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet (2001) 6.14
Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med (1986) 6.11
Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med (1993) 4.28
Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes (1996) 4.20
Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature (1998) 4.10
Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci U S A (1979) 4.09
Monitoring for anthracycline cardiotoxicity. Pediatrics (1994) 4.05
Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst (1999) 3.99
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A (2000) 3.89
Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med (2000) 3.79
The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70
Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY) JAMA (1996) 3.52
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol (1990) 3.35
Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia (1996) 3.23
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol (1981) 3.02
Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. Science (1993) 2.94
Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab (1996) 2.78
Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet (1993) 2.63
Complications of cardiac resuscitation. Chest (1987) 2.42
Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer (2000) 2.39
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes (1998) 2.38
Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J Immunol (1981) 2.30
Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health (2000) 2.26
The effects of physician supply on the early detection of colorectal cancer. J Fam Pract (1999) 2.22
Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets. Proc Natl Acad Sci U S A (1979) 2.07
Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia (2010) 2.04
Drug product selection: the Florida experience. Am J Public Health (1980) 2.02
Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med (1983) 2.00
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood (1992) 1.97
Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med (1982) 1.89
Relevance of correlates of infant deaths for significant morbidity at 1 year of age. Am J Obstet Gynecol (1980) 1.85
Standardization of IVGTT to predict IDDM. Diabetes Care (1992) 1.83
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A (1980) 1.81
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol (1998) 1.76
Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. J Immunol (1980) 1.75
Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes (1987) 1.72
Clinical severity and quality of life in children and adolescents with Rett syndrome. Neurology (2011) 1.72
Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr (1991) 1.71
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun (1996) 1.68
Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet (1997) 1.65
One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun (1999) 1.62
Confrontation visual field techniques in the detection of anterior visual pathway lesions. Ann Neurol (1981) 1.59
Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure. N Engl J Med (1985) 1.57
Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol (2000) 1.57
High prevalence of diabetes in young adult Ethiopian immigrants to Israel. Diabetes (1988) 1.56
A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med (1988) 1.55
Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes. Diabetes (1995) 1.55
The BB diabetic rat. Profound T-cell lymphocytopenia. Diabetes (1981) 1.55
A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med (1990) 1.53
ICA512 autoantibody radioassay. Diabetes (1995) 1.52
An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants. Contemp Clin Trials (2008) 1.52
Complications of CPR. Crit Care Med (1981) 1.52
Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology (Oxford) (2000) 1.52
A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Am J Dig Dis (1978) 1.51
HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet (1993) 1.50
Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia (2001) 1.49
T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci U S A (1997) 1.49
First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med (1985) 1.48
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care (1999) 1.47
Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse. J Autoimmun (2000) 1.40
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol (1999) 1.40
Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab (1991) 1.39
Immunotherapy in pre-type 1 diabetes mellitus. Diabetologia (1990) 1.39
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes (2001) 1.38
Indexes of severity: underlying concepts. Health Serv Res (1976) 1.36
Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest (2001) 1.35
Successful in utero treatment of fetal goiter and hypothyroidism. N Engl J Med (1991) 1.32
Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes (1996) 1.32
Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr (2000) 1.31
First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr (2001) 1.29
Identification of human and rodent thymic epithelium using tetanus toxin and monoclonal antibody A2B5. J Clin Invest (1983) 1.29
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Assay for islet cell antibodies. Protein A--monoclonal antibody method. Diabetes (1985) 1.28
Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. Proc Natl Acad Sci U S A (1982) 1.27
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27
Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab (2006) 1.27
Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care (1988) 1.27
Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest (1983) 1.26
Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes (1984) 1.26
Acquired defect in interleukin-2 production in patients with type I diabetes mellitus. N Engl J Med (1986) 1.25
Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation. J Immunol (1983) 1.24
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol (2001) 1.23
Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol (2004) 1.23
Genetics of type 1A diabetes. Recent Prog Horm Res (2001) 1.21
Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys (1993) 1.20
Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus. Diabetes (1984) 1.20
Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia (2002) 1.20
Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab (2010) 1.19
Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol (1995) 1.18
Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study. Cancer (1985) 1.17
HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes (1995) 1.16
Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes (1989) 1.16
Indexes of severity: conceptual development. Health Serv Res (1979) 1.15